Maxcyte, Inc. financial data

Symbol
MXCT on Nasdaq
Industry
Services-Commercial Physical & Biological Research
Location
9713 Key West Avenue,, Suite 400, Rockville, MD
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.17K % -23.6%
Quick Ratio 74.7 % +9.1%
Debt-to-equity 14.9 % +12%
Return On Equity -16 % -4.3%
Return On Assets -13.9 % -2.81%
Operating Margin -102 % +17.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 105M shares +1.84%
Common Stock, Shares, Outstanding 105M shares +1.69%
Entity Public Float 468M USD +14.4%
Common Stock, Value, Issued 1.05M USD +1.69%
Weighted Average Number of Shares Outstanding, Basic 105M shares +1.61%
Weighted Average Number of Shares Outstanding, Diluted 105M shares +1.61%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 45.6M USD +19.9%
Revenue from Contract with Customer, Excluding Assessed Tax 20.9M USD -7.03%
Research and Development Expense 23.5M USD -1.05%
Selling and Marketing Expense 27.4M USD +8.87%
General and Administrative Expense 30.6M USD +10.6%
Operating Income (Loss) -46.4M USD +1.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -11.6M USD -2.72%
Net Income (Loss) Attributable to Parent -35.7M USD +4.59%
Earnings Per Share, Basic -0.34 USD/shares +8.11%
Earnings Per Share, Diluted -0.11 USD/shares 0%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 37M USD -24.8%
Accounts Receivable, after Allowance for Credit Loss, Current 4.56M USD -44.2%
Inventory, Net 10.4M USD -17.1%
Assets, Current 173M USD -19.3%
Property, Plant and Equipment, Net 21M USD -11.8%
Operating Lease, Right-of-Use Asset 10.9M USD +13.8%
Other Assets, Noncurrent 1.05M USD +69.7%
Assets 249M USD -6.79%
Accounts Payable, Current 1.87M USD +318%
Liabilities, Current 17.6M USD +5.84%
Operating Lease, Liability, Noncurrent 17.4M USD +13.2%
Other Liabilities, Noncurrent 277K USD -79%
Liabilities 35.3M USD +5.88%
Retained Earnings (Accumulated Deficit) -206M USD -21%
Stockholders' Equity Attributable to Parent 213M USD -8.6%
Liabilities and Equity 249M USD -6.79%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -10.6M USD -144%
Net Cash Provided by (Used in) Financing Activities 703K USD -51.7%
Net Cash Provided by (Used in) Investing Activities -14.4M USD -149%
Common Stock, Shares Authorized 400M shares 0%
Common Stock, Shares, Issued 105M shares +1.69%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -24.3M USD -191%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 37M USD -24.8%
Deferred Tax Assets, Valuation Allowance 45.6M USD +38%
Operating Lease, Liability 18.3M USD +13.9%
Payments to Acquire Property, Plant, and Equipment 804K USD -48.4%
Lessee, Operating Lease, Liability, to be Paid 26.7M USD +13.2%
Operating Lease, Liability, Current 907K USD +29.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.23M USD +25.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.17M USD +25.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure +15.4%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 8.38M USD +11.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.28M USD +25.2%
Deferred Tax Assets, Operating Loss Carryforwards 22.5M USD +0.78%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.34M USD +25.2%
Additional Paid in Capital 419M USD +3.88%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 4.36M USD +9.3%
Share-based Payment Arrangement, Expense 13.5M USD 0%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%